Pacific Biosciences Of California Balance Sheet (2010-2026) | PACB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	459.79M		460.73M	428.57M	310.44M	304.43M	325.09M	353.83M	209.29M	385.65M	179.91M	76.65M	99.53M	77.98M	55.37M	58.51M	54.80M	56.47M	63.71M	56.27M
Short-term Investments (Quarter)	0.30M		583.67M	534.20M	588.71M	0.30M	447.23M	0.30M	620.58M	0.30M	451.50M	485.27M	0.34M	0.69M	334.56M	284.60M	0.30M	242.19M	215.80M	219.69M
Cash & Current Investments (Quarter)	460.09M		1,044.40M	962.77M	899.15M	304.73M	772.32M	354.13M	829.86M	385.95M	631.42M	561.91M	99.87M	78.67M	389.93M	343.11M	55.10M	298.65M	279.51M	275.96M
Receivables - Net (Quarter)	19.94M		24.24M	27.85M	27.06M	22.76M	18.79M	29.59M	24.03M	30.49M	36.62M	30.32M	32.43M	29.38M	27.52M	31.64M	32.26M	30.62M	35.45M	29.35M
Receivables - Other (Quarter)
Receivables (Quarter)	19.94M		24.24M	27.85M	27.06M	22.76M	18.79M	29.59M	24.03M	30.49M	36.62M	30.32M	32.43M	29.38M	27.52M	31.64M	32.26M	30.62M	35.45M	29.35M
Raw Materials (Quarter)	5.25M		7.99M	11.53M	15.45M	19.97M	24.14M	25.48M	25.23M	23.33M	32.43M	24.63M	29.92M	30.70M	45.27M	44.48M	45.97M	41.79M	38.64M	34.74M
Work In Process (Quarter)	9.05M		8.61M	9.20M	12.81M	13.46M	14.06M	21.70M	22.60M	27.88M	27.65M	26.30M	21.70M	18.29M	22.17M	24.91M	26.91M	25.19M	27.05M	27.35M
Finished Goods (Quarter)	3.68M		8.00M	8.89M	7.86M	10.06M	12.18M	14.78M	19.79M	17.04M	15.75M	16.41M	16.98M	16.75M	14.08M	13.43M	14.75M	16.43M	15.71M	17.84M
Inventory (Quarter)	17.98M		24.60M	29.62M	36.12M	43.49M	50.38M	61.95M	67.61M	68.26M	56.68M	67.34M	68.59M	65.74M	58.76M	54.01M	53.84M	53.15M	49.28M	51.02M
Prepaid Assets (Quarter)	6.54M		7.39M	8.44M	7.66M	13.01M	10.29M	14.38M	13.75M	15.47M	17.04M	17.14M	16.97M	17.28M	18.78M	15.47M	12.27M	11.51M	10.79M	13.16M
Current Assets (Quarter)	1,189.14M		1,101.13M	1,029.19M	970.29M	913.90M	852.07M	981.11M	935.55M	882.30M	742.05M	677.02M	628.14M	584.23M	495.68M	444.92M	413.40M	394.24M	375.05M	369.52M
Non-Current Assets
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)	25.00M		32.50M	35.51M	37.96M	39.15M	41.58M	40.83M	40.32M	40.34M	36.43M	37.29M	34.91M	31.95M	30.50M	24.79M	23.10M	22.13M	24.15M	24.38M
Goodwill (Quarter)		390.67M	409.97M	409.97M	409.97M	409.97M	409.97M	409.97M	409.97M	463.80M	52.29M	462.26M	369.06M	369.06M	317.76M	317.76M	317.76M	317.76M	317.76M	317.76M
Intangibles (Quarter)		400.00M	410.98M	410.75M	410.52M	410.29M	410.25M	410.01M	409.78M	461.84M	456.98M	450.13M	443.28M	436.43M	389.57M	18.18M	17.16M	16.14M	15.12M	14.10M
Goodwill & Intangibles (Quarter)		790.66M	820.95M	820.73M	820.50M	820.27M	820.22M	819.99M	819.75M	925.64M	509.27M	912.39M	812.34M	805.49M	707.33M	335.94M	334.92M	333.90M	332.88M	331.87M
Other Non-Current Assets (Quarter)	3.30M		5.09M	5.48M	3.22M	3.22M	3.22M	3.22M	2.72M	2.72M	2.72M	2.72M	2.26M	2.22M	9.30M	2.22M	1.53M	1.53M	1.53M	1.59M
Non-Current Assets (Quarter)	56.65M		905.84M	907.48M	905.86M	905.05M	915.01M	915.31M	912.08M	1,016.06M	1,003.97M	992.90M	881.35M	865.82M	764.77M	415.87M	412.07M	408.92M	409.03M	412.85M
Assets (Quarter)	1,245.78M		2,006.97M	1,936.67M	1,876.14M	1,818.95M	1,767.09M	1,896.42M	1,847.63M	1,898.35M	1,746.01M	1,669.92M	1,509.49M	1,450.05M	1,260.45M	860.79M	825.47M	803.16M	784.08M	782.37M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	4.76M		11.00M	17.61M	12.88M	12.85M	12.03M	17.39M	16.51M	16.11M	15.06M	21.01M	17.49M	12.06M	16.59M	14.04M	15.05M	16.36M	20.77M	13.61M
Notes Payables (Quarter)			1.61M				2.30M				0.50M
Payables (Quarter)	4.76M		12.61M	17.61M	12.88M	12.85M	14.33M	17.39M	16.51M	16.11M	15.56M	21.01M	17.49M	12.06M	16.59M	14.04M	15.05M	16.36M	20.77M	13.61M
Accumulated Expenses (Quarter)	22.91M		0.59M	19.49M	25.17M	24.89M	32.60M	19.38M	27.01M	34.66M	45.71M	21.99M	22.46M	19.18M	22.59M	29.34M	26.54M	29.17M	33.65M	33.90M
Other Accumulated Expenses (Quarter)	3.59M		5.76M	3.13M	5.91M	4.61M	7.23M	4.67M	7.34M	5.17M	8.33M	2.84M	6.75M	0.78M	3.22M	5.57M	2.59M	1.00M	2.03M	1.24M
Short term Debt (Quarter)			1.61M				172.09M	184.35M	186.32M	96.19M
Current Leases (Quarter)	4.64M		7.71M	8.06M	8.35M	8.61M	8.89M	9.02M	9.24M	9.46M	9.59M	9.77M	12.49M	10.68M	10.03M	2.42M	0.70M	0.62M	0.45M	0.28M
Current Deferred Revenue (Quarter)	9.53M		10.98M	12.73M	32.08M	30.69M	30.50M	30.87M	30.00M	22.40M	16.34M	23.40M	19.21M	17.29M	13.86M	15.24M	14.86M	16.05M	15.94M	16.33M
Total Current Liabilities (Quarter)	45.43M		71.71M	61.01M	84.40M	81.65M	263.33M	265.67M	271.41M	183.96M	95.03M	72.95M	78.39M	60.00M	66.30M	66.60M	59.75M	63.21M	72.83M	65.36M
Non-Current Liabilities
Non-Current Debt (Quarter)			2.30M				0.50M
Convertible Debt (Quarter)	895.76M		896.07M	896.22M	896.37M	896.53M	896.68M	896.84M	891.79M	892.00M	892.24M	892.54M	892.84M	893.14M	647.49M	646.21M	646.44M	645.16M	645.38M	644.11M
Non-Current Deffered Revenue (Quarter)	10.20M		25.05M	25.25M	1.83M	1.76M	1.79M	1.85M	4.99M	5.10M	5.53M	6.10M	5.70M	5.46M	5.90M	5.86M	5.71M	4.40M	3.93M	3.55M
Non-Current Deferred Tax Liability (Quarter)			0.84M				0.83M
Operating Leases (Quarter)	35.43M	18.10M	49.97M	47.74M	45.50M	43.16M	41.07M	38.97M	36.60M	34.10M	31.61M	29.05M	19.62M	16.93M	14.91M	52.90M		54.30M	56.59M	59.00M
Other Non-Current Liabilities (Quarter)	0.75M	200.00M	169.72M	168.65M	163.22M	167.50M	1.30M	184.35M	186.32M	1.05M	19.55M	0.75M	19.48M	0.75M	0.55M					8.00M
Total Non-Current Liabilities (Quarter)	986.78M	-200.00M	1,046.27M	1,033.43M	1,031.04M	1,024.86M	1,202.88M	1,019.95M	1,019.31M	1,133.56M	1,025.16M	1,020.15M	997.31M	996.18M	753.31M	769.15M	763.98M	767.07M	778.73M	772.00M
Total Liabilities (Quarter)	987.54M		1,215.98M	1,202.09M	1,194.26M	1,192.36M	1,204.18M	1,204.30M	1,205.63M	1,134.61M	1,044.71M	1,020.90M	1,016.79M	996.93M	753.85M	769.15M	763.98M	767.07M	778.73M	780.00M
Shareholder's Equity
Total Debt (Quarter)			3.91M				172.59M	184.35M	186.32M	96.19M
Common Equity (Quarter)	258.25M		790.99M	734.58M	681.89M	626.59M	562.90M	692.12M	642.00M	763.74M	701.30M	649.02M	492.70M	453.12M	506.59M	91.64M	61.49M	36.09M	5.35M	2.37M
Shareholder's Equity (Quarter)	258.25M		790.99M	734.58M	681.89M	626.59M	562.90M	692.12M	642.00M	763.74M	701.30M	649.02M	492.70M	453.12M	506.59M	91.64M	61.49M	36.09M	5.35M	2.37M
Liabilities and Shareholders Equity (Quarter)	1,245.78M		2,006.97M	1,936.67M	1,876.14M	1,818.95M	1,767.09M	1,896.42M	1,847.63M	1,898.35M	1,746.01M	1,669.92M	1,509.49M	1,450.05M	1,260.45M	860.79M	825.47M	803.16M	784.08M	782.37M
Retained Earnings (Quarter)	-0.01M		-1.09M	-1299.59M	-1370.98M	-6.26M	-1532.34M	-1.92M	-1690.19M	-1.84M	-1839.08M	-1917.25M	-0.52M	-2151.30M	-2148.93M	0.38M	0.27M	-2654.93M	-2695.30M	-0.15M
Treasury Shares (Quarter)	6.82M		7.39M	8.88M	0.01M	8.67M		12.77M	12.64M	0.54M	0.54M	0.54M	16.65M	15.74M	0.39M	0.39M	18.91M	18.12M	0.39M	19.23M

Research Tools

Pacific Biosciences Of California Balance Sheet (2010-2026) | PACB

Create an account

Sign In

Reset Password